To confirm this finding, we performed an O-propargyl-puromycin (OPP) based protein synthesis assay and detected significantly decreased mRNA translation activity in both RBM17- and EIF4A2-knockdown AML cells, respectively (Fig. 7j). The gene discussed is EIF4A2; the disease is acute myeloid leukemia.